Skip to main content
Log in

Polysensitisation to pollen due to profilin and calcium-binding protein: distribution of IgE antibodies to marker allergens in grass and birch pollen allergic rhinitis patients in southern Germany

  • Rhinology
  • Published:
European Archives of Oto-Rhino-Laryngology Aims and scope Submit manuscript

Abstract

Allergen-specific immunotherapy for grass pollen allergy has been reported to be effective in up to 85 % of patients. Sensitisation to profilin and calcium-binding protein (CBP) can possibly influence treatment results and may thus be a reason for treatment failures. During a study period of 3 years, the distribution patterns of antibodies to marker allergens were continuously investigated in all blood serum samples with a level of immunoglobulin E antibodies to timothy and birch pollen higher than 0.7 kUA/l (n = 556). Sensitisation to timothy grass pollen alone was found in 33 % of the cases, to birch pollen alone in 19 %, and to both in 48 %. The group of polysensitised patients showed an inhomogenous distribution of antibodies to marker allergens. IgE against minor allergens was detected in 40 %. Sensitisation to major allergens, especially to the major birch allergen, was not present in 13 % of the polysensitised patients. Of the patients who were sensitised to minor allergens, 82 % were sensitised to profilin, 11 % to CBP, and 8 % to both profilin and CBP. Profilin and CBP frequently cause polysensitisations to pollen. The data obtained justify the measurement of serum levels of antibodies to marker allergens in patients who are sensitised to more than one group of allergens.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. van Ree R, van Leeuwen WA, Aalberse RC (1998) How far can we simplify in vitro diagnostics for grass pollen allergy? A study with 17 whole pollen extracts and purified natural and recombinant major allergens. J Allergy Clin Immunol 102:184–190

    Article  PubMed  Google Scholar 

  2. Valenta R, Duchene M, Ebner C et al (1992) Profilins constitute a novel family of functional plant pan-allergens. J Exp Med 175:377–385

    Article  CAS  PubMed  Google Scholar 

  3. Valenta R, Hayek B, Seiberler S et al (1998) Calcium-binding allergens: from plant to man. Int Arch Allergy Immunol 117:160–166

    Article  CAS  PubMed  Google Scholar 

  4. Sekerkova A, Polackova M, Striz I (2012) Detection of Phl p 1, Phl p 5, Phl p 7 and Phl p 12 specific IgE antibodies in the sera of children and adult patients allergic to phleum pollen. Allergol Int 61:339–346

    CAS  PubMed  Google Scholar 

  5. Bousquet J, Lockey RF, Malling HJ (1998) WHO position paper. Allergen immunotherapy: therapeutic vaccines for allergic disease. J Allergy Clin Immunol 102:558–562

    Article  CAS  PubMed  Google Scholar 

  6. Larche M, Akdis CA, Valenta R (2006) Immunological mechanisms of allergen-specific immunotherapy. Nat Rev Immunol 10:761–771

    Article  Google Scholar 

  7. Valenta R, Ball T, Focke M et al (2004) Immunotherapy of allergic disease. Adv Immunol 82:105–153

    Article  CAS  PubMed  Google Scholar 

  8. Durham SR, Walker SM, Varga EM et al (1999) Long-term clinical efficacy of grass-pollen immunotherapy. N Engl J Med 341:468–475

    Article  CAS  PubMed  Google Scholar 

  9. Moller HJ, Dreborg S, Ferdousi HA et al (2002) Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT study). J Allergy Clin Immunol 109:251–256

    Article  PubMed  Google Scholar 

  10. Calderon MA, Alves B, Jacobson M et al (2007) Allergen injection immunotherapy for seasonal allergic rhinitis. Cochrane Database Syst Rev (1):CD001936

  11. Klimek L, Mewes T, Wolf H et al (2005) The effects of short-term immunotherapy using molecular standardized grass and rye allergens compared with systemic drug treatment on rhinoconjunctivitis symptoms, skin sensitivity, and specific nasal reactivity. Otolaryngol Head Neck Surg 133:538–543

    Article  CAS  PubMed  Google Scholar 

  12. van Ree R (2003) The CREATE project: a new beginning of allergen standardization based on mass units of major allergens. In: Löwer J, Becker W-M, Vieths S (eds) Regulatory control and standardization of allergenic extracts. Druck- und Verlagshaus Sperlich. Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf a M, Frankfurt, pp 70–73 (discussion pp 74–75)

    Google Scholar 

  13. Valenta R, Lidholm J, Hayek B et al (1999) The recombinant allergen-based concept of component-resolved diagnostics and immunotherapy (CRD and CRIT). Clin Exp Allergy 29:896–904

    Article  CAS  PubMed  Google Scholar 

  14. Valenta R, Kraft D (2002) From allergen structure to new forms of allergen-specific immunotherapy. Curr Opin Immunol 14:718–727

    Article  CAS  PubMed  Google Scholar 

  15. www.allergome.com. Accessed 18 Dec 2012

  16. Ferreira F, Hawranek T, Gruber P et al (2004) Allergic cross-reactivity: from gene to the clinic. Allergy 59:243–267

    Article  CAS  PubMed  Google Scholar 

  17. Kazemi-Shirazi L, Niederberger V, Linhart B et al (2002) Recombinant marker allergens: diagnostic gatekeepers for the treatment of allergy. Int Arch Allergy Immunol 127:259–268

    Article  CAS  PubMed  Google Scholar 

  18. Andersson K, Lidholm J (2003) Characteristics and immunology of grass pollen allergens. Int Arch Allergy Immunol 130:87–107

    Article  CAS  PubMed  Google Scholar 

  19. Mari A, Wallner F, Ferreira F (2003) Fagales pollen sensitization in a birch-free area: a respiratory cohort survey using Fagales pollen extracts and birch recombinant allergens (rBet v 1, rBet v 2, rBet v 4). Clin Exp Allergy 33:1419–1428

    Article  CAS  PubMed  Google Scholar 

  20. Rossi RE, Monasterolo G, Monasterolo S (2003) Detection of specific IgE antibodies in the sera of patients allergic to birch pollen using recombinant allergens Bet v 1, Bet v 2, Bet v 4: evaluation of different IgE reactivity profiles. Allergy 58:929–932

    Article  CAS  PubMed  Google Scholar 

  21. Asero R, Valenta D (2011) Are anti-Phl p 12 IgE levels predictive of oral allergy syndrome in profilin hypersensitive patients? Eur Ann Allergy Clin Immunol 43:184–187

    CAS  PubMed  Google Scholar 

  22. Santos A, van Ree R (2011) Profilins: mimickers of allergy or relevant allergens? Int Arch Allergy Immunol 155:191–204

    Article  CAS  PubMed  Google Scholar 

  23. Weber RW (2007) Cross-reactivity of pollen allergens: impact on allergen immunotherapy. Ann Allergy Asthma Immunol 99:203–211

    Article  PubMed  Google Scholar 

  24. Mellon MB, Frank BT, Fang KC (2002) Mast cell alpha-chymase reduces IgE recognition of birch pollen profilin by cleaving antibody-binding epitopes. J Immunol 168:290–297

    CAS  PubMed  Google Scholar 

  25. Grote M, Westritschnig K, Valenta R (2008) Immunogold electron microscopic localization of the 2 EF-hand calcium-binding pollen allergen Phl p 7 and its homologues in pollens of grasses, weeds and trees. Int Arch Allergy Immunol 146:113–121

    Article  CAS  PubMed  Google Scholar 

  26. Wopfner N, Dissertori O, Ferreira F, Lackner P (2007) Calcium-binding proteins and their role in allergic diseases. Immunol Allergy Clin North Am 27:29–44

    Article  PubMed  Google Scholar 

  27. Asero R, Jimeno L, Barber D (2010) Preliminary results of a skin prick test-based study of the prevalence and clinical impact of hypersensitivity to pollen panallergens (polcalcin and profilin). J Investig Allergol Clin Immunol 20:35–38

    CAS  PubMed  Google Scholar 

  28. Twardosz-Kropfmueller A, Singh MB et al (2010) Association of allergic patients’ phenotypes with IgE reactivity to recombinant pollen marker allergens. Allergy 65:296–303

    Article  CAS  Google Scholar 

  29. Canis M, Gröger M, Becker S, Klemens C, Kramer MF (2011) Recombinant marker allergens in diagnosis of patients with allergic rhinoconjunctivitis to tree and grass pollens. Am J Rhinol Allergy 25:36–39

    Article  PubMed  Google Scholar 

  30. Canis M, Gröger M, Becker S, Klemens C, Kramer MF (2010) Recombinant allergen profiles and health-related quality of life in seasonal allergic rhinitis. Allergy Asthma Proc 31:219–226

    Article  PubMed  Google Scholar 

  31. Schäfer T, Ring J (1997) Epidemiology of allergic diseases. Allergy 52(Suppl 38):14–22

    Article  PubMed  Google Scholar 

  32. Ring J, Bachert C, Bauer CP, Czech W (eds) (2009) Weißbuch Allergie in Deutschland, 3rd revised and extended edn, Urban & Vogel. ISBN: 3-89935-245-9, ISBN-13: 9783899352450

Download references

Conflict of interest

G.M. has received honoraria for scientific presentations from Phadia (Freiburg, Germany). H.M. declares no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to G. Muehlmeier.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Muehlmeier, G., Maier, H. Polysensitisation to pollen due to profilin and calcium-binding protein: distribution of IgE antibodies to marker allergens in grass and birch pollen allergic rhinitis patients in southern Germany. Eur Arch Otorhinolaryngol 271, 719–725 (2014). https://doi.org/10.1007/s00405-013-2609-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00405-013-2609-7

Keywords

Navigation